Table 1. .
Description of Included Studies and Assessment of Methodologic Quality Extended on Next Page
| Authors (Year) |
Injured Group |
||||
| Group Included, N |
Age, y (Mean ± SD or Range) |
Time Since Surgery |
Time Since Injury |
Gait Speed, m/s (Mean ± SD or Set Speed) |
|
| Butler et al27 (2009) | ACLR = 17 | 23.6 ± 5.8 | 63.6 ± 52.8 mo | NA | 1.4 ± 0.1 |
| Chen et al26 (2012) | ACLD = 10 | 35.5 ± 8.5 | NA | NA | Not reported |
| Di Stasi and Snyder- Mackler28 (2012) | ACLD = 21 | Men = 25.0 ± 8.7 | NA | Men = 13.1 ± 9.3 wk | Not reported |
| Women = 33.7 ± 12.6 | Women = 7.4 ± 5.7 wk | ||||
| Di Stasi et al9 (2013) | ACLR = 42 | Pass return to play = 25.4 ± 9.9 | 6.0 mo | NA | Pass = 1.5 ± 0.1 |
| Fail return to play = 31.4 ± 12.2 | Fail = 1.6 ± 0.1 | ||||
| Ferber et al29 (2002) | ACLR = 10 | 27.7 ± 9.1 | 3.0 mo | 5.7 ± 5.1 y | Not reported |
| ACLD = 10 | |||||
| Georgoulis et al30 (2003) | ACLR = 21 | ACLR = 25.0 ± 4.0 | 30.0 ± 16.9 wk | 7.6 ± 4.3 wk | Not reported |
| ACLD = 13 | ACLD = 26.0 ± 5.0 | ||||
| Houck et al31 (2007) | ACLD = 16 | 24.1 ± 9.1 | NA | 8.7 ± 14.5 mo | 2.0 |
| Knoll et al32 (2004) | ACLD = 21 | 29.9 ± 6.5 | 6 wk and 4, 8, and 12 mo | NA | 0.8 |
| ACLR = 21 | |||||
| Knoll et al46 (2004) | ACLR = 21 | 29.9 ± 6.5 | 6 wk and 4, 8, and 12 mo | NA | 0.8 |
| ACLD = 21 | |||||
| Lewek et al33 (2002) | ACLR = 10 | ACLR = 25.0 ± 7.8 | 20.8 ± 9.4 wk | <6.0 mo | 2.0 |
| ACLD = 10 | ACLD = 28.1 ± 8.8 | ||||
| Lindstrom et al34 (2010) | ACLD = 16 | 17−52 | NA | 35 mo | Not reported |
| Noehren et al47 (2013) | ACLR = 20 | 25.0 ± 6.2 | 5.2 ± 3.2 yrs | NA | 1.5 |
| Noyes et al35 (1992) | ACLD = 32 | 27.0 (15.0−41.0) | NA | NA | 1.1 ± 0.1 |
| Patterson et al36 (2014) | ACLR = 17 | 23.7 ± 3.1 | NA | 3.5 ± 3.2 y | 1.4 ± 0.1 |
| Roberts et al37 (1999) | ACLD = 18 | 35.0 | NA | 47.2 ± 47.2 mo | Not reported |
| Roewer et al38 (2011) | ACLR = 26 | 29.6 ± 10.7 | 6.0 mo and 24.0 mo | NA | 1.6 ± 0.1 |
| ACLD = 26 | |||||
| Sato et al44 (2013) | ACLR = 7 | 21.3 ± 4.9 | 14.3 ± 1.8 mo | NA | NA |
| Shin et al19 (2009) | ACLR = 24 | 33.6 ± 9.2 | 34.0 ± 34.0 mo | 43.0 ± 38.0 mo | 1.4 |
| Timoney et al18 (1993) | ACLR = 10 | NA | 10.0 mo (range = 9.0− 12.0 mo) | 30.0 mo (range = 1.0−66.0 mo) | 1.2 |
| Torry et al39 (2004) | ACLD = 16 | 28.1 ± 12.7 | N/A | >2.0 y | Not reported |
| Wang et al45 (2013) | ACLR = 24 (transtibial technique = 12, anteromedial portal = 12) | Transtibial technique = 32.8 ± 7.2 | Transtibial technique = 17.1 ± 10.6 mo | NA | Transtibial technique = 1.2 ± 0.2 |
| Anteromedial portal = 29.6 ± 7.2 | Anteromedial portal = 8.8 ± 4.3 mo | Anteromedial portal = 1.1 ± 0.1 | |||
| Webster et al40 (2005) | ACLR = 34 (hamstrings autograft = 17, bone-patellar tendon-bone autograft = 17) | Hamstrings autograft = 26.8 ± 8.0 | Hamstrings autograft = 9.3 ± 2.2 mo | NA | Hamstrings autograft = 1.4 ± 0.2 |
| Bone-patellar tendon-bone autograft = 23.8 ± 5.0 | Bone-patellar tendon-bone autograft = 11.0 ± 1.9 mo | Bone-patellar tendon-bone autograft = 1.4 ± 0.2 | |||
| Webster and Feller42 (2011) | ACLR = 36 (hamstrings autograft = 18, bone-patellar tendon-bone autograft = 18) | Hamstrings autograft = 26.6 ± 6.0 | Hamstrings autograft = 9.0 ± 2.4 mo | NA | Hamstrings autograft = 1.4 ± 0.2 |
| Bone-patellar tendon-bone autograft = 23.8 ± 6.0 | Bone-patellar tendon-bone autograft = 10.9 ± 2.0 mo | Bone-patellar tendon-bone autograft = 1.4 ± 0.2 | |||
| Webster et al17 (2012) | ACLR = 36 | Males = 27.4 ± 6.6 | Males = 20.3 ± 11.4 mo | NA | Males = 1.4 ± 0.2 |
| Females = 27.7 ± 6.8 | Females = 19.8 ± 11.6 mo | Females = 1.4 ± 0.1 | |||
| Webster and Feller41 (2012) | ACLR = 32 (semitendinosus = 16, bone-patellar tendon-bone = 16) | Semitendinosus = 27.5 ± 6.0 | Semitendinosus = 9.4 ± 3.0 mo | Semitendinosus = 10.7 ± 9.0 wk | Semitendinosus = 1.4 ± 0.2 |
| Bone-patellar tendon-bone = 23.8 ± 6.0 | Bone-patellar tendon-bone = 11.2 ± 2.0 mo | Bone-patellar tendon-bone = 11.9 ± 11.0 wk | Bone-patellar tendon-bone = 1.4 ± 0.2 wk | ||
| Webster et al48 (2012) | ACLR = 16 | 26.0 ± 6.0 | Time 1 = 10.0 ± 2.0 mo | NA | Time 1 = 1.4 ± 0.2 |
| Time 2 = 39.6 ± 4.8 mo | Time 2 = 1.4 ± 0.2 | ||||
| Zabala et al43 (2013) | ACLR = 45 | 29.5 ± 6.1 | 26.0 mo (range = 22.0− 36.0 mo) | NA | 1.4 ± 0.1 |
Abbreviations: ACLD, anterior cruciate ligament deficient; ACLR, anterior cruciate ligament reconstructed; NA, not applicable; PEDro, Physiotherapy Evidence Database.
a
Score range = 0–10.
b
Score range = 0–32.